Lucid Diagnostics LUCD EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Lucid Diagnostics’s reported figures.
The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lucid Diagnostics's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lucid Diagnostics's EBITDA?
- Lucid Diagnostics (LUCD) reported EBITDA of -$11.89M in Q1 2026.
- How has Lucid Diagnostics's EBITDA changed year-over-year?
- Lucid Diagnostics's EBITDA increased by 3.0% year-over-year, from -$12.27M to -$11.89M.
- What is the long-term trend for Lucid Diagnostics's EBITDA?
- Over 3 years (2022 to 2025), Lucid Diagnostics's EBITDA has grown at a -3.5% compound annual growth rate (CAGR), from -$54.32M to -$48.77M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.